Convergent evidence for impaired AKT1-GSK3β signaling in schizophreniaEffat S. Emamian, Joseph A. Gogos|Nature Genetics|2004Cited by 919
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypesColm O’Tuathaigh, John L. Waddington, Jeremy Walsh et al.|The International Journal of Neuropsychopharmacology|2011Cited by 62